We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-14.86%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$134B
AUM Growth
-$30.1B
Cap. Flow
-$1.57B
Cap. Flow %
-1.17%
Top 10 Hldgs %
29.15%
Holding
6,955
New
507
Increased
2,096
Reduced
2,889
Closed
579

Sector Composition

Rank Sector Weight
1 Technology 10.07%
2 Financials 5.69%
3 Healthcare 5.49%
4 Consumer Discretionary 4.41%
5 Industrials 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXTS
6551
Nexentis Technologies
NXTS
$2.62M
0
-$1K
SER icon
6552
Serina Therapeutics
SER
$31M
-73
Closed -$2K
TRAW icon
6553
Traws Pharma
TRAW
$7.43M
$0 ﹤0.01%
+5
New +$169
ATYR
6554
aTyr Pharma
ATYR
$46.4M
-650
Closed -$3K
QXO
6555
QXO Inc
QXO
$14.2B
0
ORKA
6556
Oruka Therapeutics
ORKA
$5.56B
-149
Closed -$4K
SCNX
6557
Scienture Holdings
SCNX
$15M
-20
Closed -$1K
CLYM
6558
Climb Bio
CLYM
$735M
$0 ﹤0.01%
53
-371
-88% -$1.75K
HURA
6559
TuHURA Biosciences
HURA
$134M
0
IRD
6560
Opus Genetics
IRD
$254M
-66
Closed
FLG
6561
CALL
Flagstar Bank National Association
FLG
$5.77B
-83,333
Closed -$2.68M
CIRC
6562
Circle8 Group
CIRC
$71.3M
-46
Closed -$3K
RNTX
6563
Rein Therapeutics
RNTX
$67.7M
-1,506
Closed -$15K
QQQH
6564
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$375M
$0 ﹤0.01%
12
-4
-25% -$177
SPLP
6565
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
-12
Closed
PEV
6566
DELISTED
Phoenix Motor Inc. Common Stock
PEV
$0 ﹤0.01%
+57
New +$248
ITCI
6567
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-30,000
Closed -$1.84M
ITCI
6568
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-30,000
Closed -$1.84M
ATXI
6569
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
0
BEST
6570
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$0 ﹤0.01%
1
-111,110
-100% -$780K
MVPS
6571
DELISTED
Amplify Thematic All-Stars ETF
MVPS
-76
Closed -$2K
PWUPU
6572
DELISTED
PowerUp Acquisition Corp. Unit
PWUPU
-27,901
Closed -$280K
SNAX
6573
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
-1,000
Closed -$19K
VINC
6574
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$0 ﹤0.01%
8
-22
-73% -$978
PIK
6575
DELISTED
Kidpik Corp. Common Stock
PIK
-216
Closed -$5K

Similar funds

Citigroup's Q2 2022 Portfolio in Review

As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
  • Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
  • Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
  • Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
  • Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
  • Citigroup opened 507 new positions and closed 579 in Q2 2022.
  • Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.